Case Study: How the Australian Epilepsy Project taps tech to empower patients
2 Articles
2 Articles
New study finds an epilepsy drug could be affective for people with depression | Oxford Health NHS Foundation Trust
The study looked at how ezogabine affects certain brain activities in people with depression and anhedonia, the inability to experience pleasure or joy, which is a common symptom of many mental health conditions. Study participants were given either ezogabine or a placebo for five weeks and received MRI scans to assess activity in reward-related brain circuits. The results showed that ezogabine… Source
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage